News | Neuro Imaging | March 18, 2019

Non-Contrast MRI Effective in Monitoring MS Patients

New study suggests contrast enhancement with gadolinium could be omitted from routine follow-up scans

Non-Contrast MRI Effective in Monitoring MS Patients

March 18, 2019 — Brain magnetic resonance imaging (MRI) without contrast agent is just as effective as the contrast-enhanced approach for monitoring disease progression in patients with multiple sclerosis (MS), according to a new study in the journal Radiology. The findings support the possibility that contrast enhancement can be omitted from routine follow-up scans.

MS is a disease in which the immune system attacks the body’s central nervous system, including the brain and spinal cord. This can lead to vision problems, numbness and a host of other symptoms. Damaged areas of the brain develop scar tissue, or lesions, that are visible on MRI.

MRI with the administration of gadolinium-based contrast material is widely considered obligatory for follow-up scans of patients with MS. Gadolinium, a heavy metal, enhances the images and helps provide important diagnostic information, but it leads to both prolonged scan times and increased costs. There is also evidence that some of the metal remains in the body after contrast administration, although the long-term clinical impact of these deposits is unclear.

“These factors warrant evaluation of strategies for reducing or omitting contrast agent, especially in MS patients who often accumulate a high number of MRI scans over their lifetimes,” said study senior author Benedikt Wiestler, M.D., from the Technische Universität München in Munich, Germany.

Advances in non-contrast MRI image acquisition and post-processing technology, along with the increasing availability of powerful 3T MRI machines, have raised the possibility that non-enhanced scans could have a role in MS follow-up imaging.

To learn more, Wiestler and colleagues used MRI to assess new or enlarged lesions in 359 patients with MS. Of 507 follow-up scans, 264 showed interval progression, defined as at least one new or unequivocally enlarged lesion on follow-up MRI scans. There were a total of 1,992 new or enlarged lesions. With 3T MRI, the assessment of interval progression did not differ significantly between the contrast-enhanced and nonenhanced images.

“In over 500 follow-up scans, we missed only four of 1,992 new or enlarged lesions,” Wiestler said. “Importantly, we did not miss disease activity in the non-enhanced scans in a single follow-up scan.”

Wiestler credited an image subtraction pipeline developed and researched at his facility for the powerful sensitivity of the non-contrast MRI in detecting newly occurring lesions. The approach combines 3-D MRI and subtraction techniques, which cancel out unchanged areas in the follow-up image, substantially improving visualization of new or enlarging white matter lesions.

This combination of 3-D sequences and subtraction techniques is key to improving sensitivity for detecting newly occurred lesions, Wiestler said.

“Several vendors have made tools for generating subtraction images commercially available,” he said. “Implementing such tools into the routine clinical workflow will help to make the use of contrast agent dispensable in routine follow-up imaging of MS patients.”

For more information: www.pubs.rsna.org/journal.radiology

 

Reference

1. Eichinger P., Schön S., Pongratz V., et al. “Accuracy of Unenhanced MRI in the Detection of New Brain Lesions in Multiple Sclerosis.” Radiology, March 12, 2019. https://doi.org/10.1148/radiol.2019181568

Related Content

Samsung Demonstrates Viability of Lower Dose Digital Radiography Algorithm for Pediatric Patients
News | Digital Radiography (DR) | April 24, 2019
Samsung announced that its new image post-processing engine (IPE), S-Vue 3.02, recently received U.S. Food and Drug...
ITN Wins Jesse H. Neal Award for Best Technical Content
News | Radiology Business | April 24, 2019
April 24, 2019 — Imaging Technology News (ITN) was recently named the 2019 Jesse H.
Konica Minolta KDR AU and KDR Primary DR Systems Receive Seismic Certification
News | Digital Radiography (DR) | April 24, 2019
Konica Minolta Healthcare Americas Inc., announced its KDR Advanced U-Arm and KDR Primary Digital Radiography System...
New Study Redefines Therapeutic Dose Guidelines for Non-Small Cell Lung Cancer
News | Lung Cancer | April 23, 2019
Non-small cell lung cancer is a common cancer for both men and women. Many people who are diagnosed with this type of...
Konica Minolta Dynamic Digital Radiography Receives FDA Clearance

With DDR, orthopedists and MSK specialists can acquire a full view of the MSK system in the supine and prone positions to view changes in the bone and articulations throughout the full range of motion. Image courtesy of Konica Minolta Healthcare Americas.

Technology | Digital Radiography (DR) | April 23, 2019
Konica Minolta Healthcare Americas Inc. announced that its Dynamic Digital Radiography (DDR) technology, introduced at...
Comparison of state Medicaid fees for radiation oncology services for breast cancer and nonradiation oncology services per the Kaiser Family Foundation Index

Fig. 1: Comparison of state Medicaid fees for radiation oncology services for breast cancer and nonradiation oncology services per the Kaiser Family Foundation Index. (Agarwal et al, Red Journal, 2019) Credit: Elsevier

News | Radiation Therapy | April 22, 2019
April 22, 2019 — A new study finds wide state
Stereotactic Radiosurgery Effective for Pediatric Arteriovenous Malformation Patients
News | Radiation Therapy | April 19, 2019
Ching-Jen Chen, M.D., of the neurosurgery department at the University of Virginia (UVA) Health System, was the winner...
Video Plus Brochure Helps Patients Make Lung Cancer Scan Decision

Image courtesy of the American Thoracic Society

News | Lung Cancer | April 19, 2019
A short video describing the potential benefits and risks of low-dose computed tomography (CT) screening for lung...
FDA Clears GE's Deep Learning Image Reconstruction Engine
Technology | Computed Tomography (CT) | April 19, 2019
GE Healthcare has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) of its Deep Learning Image...
Artificial Intelligence Performs As Well As Experienced Radiologists in Detecting Prostate Cancer
News | Artificial Intelligence | April 18, 2019
University of California Los Angeles (UCLA) researchers have developed a new artificial intelligence (AI) system to...